Health Catalyst (HCAT) Tops Q2 EPS by 7c, Revenues Beat; Offers 3Q Revenue Guidance Above Consensus, FY20 Revenue Mid-Point Guidance Above Consensus

Go back to Health Catalyst (HCAT) Tops Q2 EPS by 7c, Revenues Beat; Offers 3Q Revenue Guidance Above Consensus, FY20 Revenue Mid-Point Guidance Above Consensus
(NASDAQ: HCAT) Delayed: 1.85 +0.10 (5.71%)
Previous Close $1.75    52 Week High
Open $1.76    52 Week Low
Day High $1.89    P/E N/A 
Day Low $1.76    EPS
Volume 919,701